Home > Latest > Body

The U.S. Food and Drug Administration (FDA) panel voted 11-0 that the benefits of Eli Lilly's Alzheimer's drug outweighed the risks.

clock
2024-06-11 03:55:23
The U.S. Food and Drug Administration (FDA) panel voted 11-0 that the benefits of Eli Lilly's Alzheimer's drug outweighed the risks.